124 related articles for article (PubMed ID: 1438406)
1. Purging with 4-hydroperoxycyclophosphamide combinations.
Jones RJ; Miller CB; Rowley SD
Prog Clin Biol Res; 1992; 377():1-9; discussion 10-1. PubMed ID: 1438406
[No Abstract] [Full Text] [Related]
2. Effect of Ethiofos on cytotoxicity of pharmacological purging protocols used for autologous marrow grafts in acute lymphoblastic leukemia.
Skala JP; Rogers PC; Chan KW; Rodriguez WC
Prog Clin Biol Res; 1992; 377():57-62. PubMed ID: 1332075
[No Abstract] [Full Text] [Related]
3. In vitro effects of Ilmofosine on acute lymphoblastic leukemia cells and on normal hemopoietic cells.
Skala JP; Rogers PC; Chan KW; Khangura SS; Rodriguez WC
Prog Clin Biol Res; 1992; 377():63-9. PubMed ID: 1438445
[No Abstract] [Full Text] [Related]
4. Effects of mafosfamide on the clonogenic cells in precursor B acute lymphoblastic leukemia: significance for ex vivo purging of bone marrow.
Kramer B; Makrynikola V; Bradstock K
Prog Clin Biol Res; 1992; 377():41-7. PubMed ID: 1438438
[No Abstract] [Full Text] [Related]
5. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
Makrynikola V; Kabral A; Bradstock KF
Bone Marrow Transplant; 1991 Nov; 8(5):351-5. PubMed ID: 1768969
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of combination drug purging for autologous bone marrow transplantation.
Jones RJ; Miller CB; Zehnbauer BA; Rowley SD; Colvin OM; Sensenbrenner LL
Bone Marrow Transplant; 1990 May; 5(5):301-7. PubMed ID: 2350626
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of purging clonogenic leukemia cells using ether lipid and hyperthermia for autologous bone marrow transplantation.
Min WS; Park HM; Han CH; Park JW; Kim CC; Kim DJ
Prog Clin Biol Res; 1992; 377():87-95. PubMed ID: 1438449
[No Abstract] [Full Text] [Related]
8. Purging of acute lymphoblastic leukemia by long-term marrow culture.
Douay L; Ozsahin H; Barbu V; Fabrega S; Giarratana MC; Da WM; Allieri A; Gorin NC
Prog Clin Biol Res; 1992; 377():205-13; discussion 214. PubMed ID: 1438417
[No Abstract] [Full Text] [Related]
9. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
10. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
Gidáli J; Fehér I
Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
[TBL] [Abstract][Full Text] [Related]
11. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
12. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update.
Peters RH; Brandon CS; Avila LA; Gale GR; Stuart RK
Prog Clin Biol Res; 1990; 333():57-68. PubMed ID: 2309001
[TBL] [Abstract][Full Text] [Related]
13. Drug-mediated marrow purging: mafosfamide in adult acute leukemia in remission. The experience of the Italian study group.
Rizzoli U; Mangoni L; Carella AM; Aglietta M; Porcellini A; Coleselli P; Angrilli F; Alessandrino EP; Madon E; Locatelli F
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():190-4. PubMed ID: 2653502
[No Abstract] [Full Text] [Related]
14. Phase I study of combination drug purging for autologous bone marrow transplantation.
Rowley SD; Miller CB; Piantadosi S; Davis JM; Santos GW; Jones RJ
J Clin Oncol; 1991 Dec; 9(12):2210-8. PubMed ID: 1960561
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma purging by immunorosette depletion.
Slaper-Cortenbach IC; de Vries-van Rossen A; Huijbens RJ; van Leeuwen EF; Figdor CG
Prog Clin Biol Res; 1992; 377():147-62. PubMed ID: 1438411
[No Abstract] [Full Text] [Related]
16. Bone marrow purging with antisense oligodeoxynucleotides.
Gewirtz AM
Prog Clin Biol Res; 1992; 377():215-24; discussion 225-6. PubMed ID: 1438418
[No Abstract] [Full Text] [Related]
17. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
[TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation after in vitro purging with monoclonal antibodies and complement in acute lymphoblastic leukemia.
Perez-Oteyza J; Larana JG; Brieva J; Roldan E; Odriozola J; Maldonado M; Otheo E; Munoz A; Bootello A; Navarro JL
Prog Clin Biol Res; 1992; 377():163-8. PubMed ID: 1438412
[No Abstract] [Full Text] [Related]
19. High dose therapy and autologous bone marrow transplant (ABMT) in acute leukemia: is purging necessary?
Dicke KA; Spinolo JA
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():184-6. PubMed ID: 2653500
[TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplant using 4-HC, VP-16 purged bone marrow for acute non-lymphoblastic leukemia.
Gulati SC; Shank B; Sarris A; Berman E; Gee T; Cunningham I; Flomenberg N; O'Reilly RJ; Clarkson B
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():116-8. PubMed ID: 2653485
[No Abstract] [Full Text] [Related]
[Next] [New Search]